➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Baxter
Moodys
Colorcon
Dow

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

RALOXIFENE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Raloxifene Hydrochloride, and when can generic versions of Raloxifene Hydrochloride launch?

Raloxifene Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc. and is included in eight NDAs.

The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Raloxifene Hydrochloride

A generic version of RALOXIFENE HYDROCHLORIDE was approved as raloxifene hydrochloride by TEVA PHARMS USA on March 4th, 2014.

  Get Started for $10

Drug patent expirations by year for RALOXIFENE HYDROCHLORIDE
Recent Clinical Trials for RALOXIFENE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Monash HealthPhase 4
Massachusetts General HospitalPhase 4
Laboratorios Grossman, S.A.Phase 3

See all RALOXIFENE HYDROCHLORIDE clinical trials

Pharmacology for RALOXIFENE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for RALOXIFENE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for RALOXIFENE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
EVISTA TABLET;ORAL raloxifene hydrochloride 020815

US Patents and Regulatory Information for RALOXIFENE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 208206-001 Apr 8, 2016 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva Pharms Usa RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 078193-001 Mar 4, 2014 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Glenmark Pharms Ltd RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 204491-001 Mar 22, 2016 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Watson Labs Inc RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 200825-001 Jan 21, 2015 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Aurobindo Pharma Ltd RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 204310-001 Aug 28, 2015 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Cadila Pharms Ltd RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 211324-001 Aug 18, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Sciegen Pharms Inc RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 206384-001 Oct 12, 2016 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Express Scripts
AstraZeneca
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.